In one paragraphArticle in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Tereza VodičkováInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava and Medical Faculty Ostrava, 703 52 Ostrava, Czech Republic.ORCID 0000-0003-3354-3899 Mária WozniakováInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava and Medical Faculty Ostrava, 703 52 Ostrava, Czech Republic.ORCID 0000-0001-6455-1782 Vladimír ŽidlíkInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava and Medical Faculty Ostrava, 703 52 Ostrava, Czech Republic.ORCID 0000-0002-3179-9252 Jana ŽmolíkováEUC Laboratories CGB, a.s., 703 00 Ostrava, Czech Republic.
Adéla KondéDepartment of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 708 00 Ostrava, Czech Republic.ORCID 0000-0002-0511-0749 Jana SchwarzerováInstitute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava and Medical Faculty Ostrava, 703 52 Ostrava, Czech Republic.ORCID 0000-0003-2918-9313 Jan BouchalDepartment of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Palacky University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic.ORCID 0000-0003-4842-1720 Funding
MEYS and the European Regional Development Fund DRO 61989592, BBMRI-CZ No. CZ.02.1.01/0.0/0.0/16_013/0001674 and Programme EXCELES, ID Project no. LX22NPO5102Ministry of Health of the Czech Republic NW24-03-00265, DRO FNOs/2020 and DRO FNOl00098892
6 · The paper itselfAbstract
The tumor suppressor gene
Indexed as
Gene DeletionHomeodomain ProteinsProstatic NeoplasmsTranscription FactorsAgedDisease ProgressionGene Expression Regulation, NeoplasticHumansMaleMiddle AgedHomeodomain ProteinsNKX3-1 protein, humanTranscription FactorsFISHimmunohistochemistryLPLNKX3.1prostate cancerwhole-genome sequencing
Identifiers
PMID40563400
PMCPMC12190382
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390